Amalgamated Bank Medpace Holdings, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 12,684 shares of MEDP stock, worth $4.42 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

12,684

Previous 12,311 3.03%

Holding current value

$4.42 Million

Previous $5.07 Million 16.49%

% of portfolio

0.03%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$320.58 - $457.29 $119,576 - $170,569	373 Added 3.03%	12,684 $4.23 Million
Q2 2024 Aug 12, 2024	SELL	$372.0 - $424.34 $242,916 - $277,094	-653 Reduced 5.04%	12,311 $5.07 Million
Q1 2024 Apr 23, 2024	SELL	$284.87 - $413.31 $1.05 Million - $1.52 Million	-3,686 Reduced 22.14%	12,964 $5.24 Million
Q4 2023 Feb 06, 2024	SELL	$227.52 - $312.68 $57,107 - $78,482	-251 Reduced 1.49%	16,650 $5.1 Million
Q3 2023 Nov 08, 2023	SELL	$233.98 - $281.67 $160,042 - $192,662	-684 Reduced 3.89%	16,901 $4.09 Million
Q2 2023 Aug 11, 2023	BUY	$187.26 - $240.17 $120,033 - $153,948	641 Added 3.78%	17,585 $4.22 Million
Q1 2023 May 02, 2023	SELL	$174.31 - $239.52 $167,337 - $229,939	-960 Reduced 5.36%	16,944 $3.19 Million
Q4 2022 Feb 10, 2023	BUY	$153.06 - $226.57 $48,060 - $71,142	314 Added 1.79%	17,904 $3.8 Million
Q3 2022 Nov 09, 2022	SELL	$145.13 - $182.49 $115,233 - $144,897	-794 Reduced 4.32%	17,590 $2.77 Million
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $155,849 - $201,131	-1,197 Reduced 6.11%	18,384 $2.75 Million
Q1 2022 Jun 30, 2022	SELL	$138.87 - $214.31 $129,565 - $199,951	-933 Reduced 4.55%	19,581 $3.2 Million
Q4 2021 Feb 15, 2022	BUY	$182.74 - $227.9 $23,207 - $28,943	127 Added 0.62%	20,514 $4.47 Million
Q3 2021 Oct 29, 2021	SELL	$170.18 - $198.21 $271,266 - $315,946	-1,594 Reduced 7.25%	20,387 $3.86 Million
Q2 2021 Aug 16, 2021	BUY	$158.62 - $194.3 $2.83 Million - $3.46 Million	17,811 Added 427.12%	21,981 $3.88 Million
Q1 2021 May 13, 2021	SELL	$132.02 - $168.26 $50,695 - $64,611	-384 Reduced 8.43%	4,170 $684,000
Q4 2020 Feb 12, 2021	BUY	$109.38 - $149.19 $9,625 - $13,128	88 Added 1.97%	4,554 $633,000
Q3 2020 Oct 30, 2020	SELL	$92.95 - $130.61 $13,198 - $18,546	-142 Reduced 3.08%	4,466 $499,000
Q2 2020 Aug 10, 2020	SELL	$68.08 - $95.68 $33,563 - $47,170	-493 Reduced 9.66%	4,608 $429,000
Q1 2020 May 13, 2020	SELL	$61.71 - $101.95 $5,183 - $8,563	-84 Reduced 1.62%	5,101 $374,000
Q4 2019 Feb 13, 2020	BUY	$70.08 - $84.64 $7,568 - $9,141	108 Added 2.13%	5,185 $436,000
Q3 2019 Nov 13, 2019	SELL	$62.38 - $85.89 $5,489 - $7,558	-88 Reduced 1.7%	5,077 $427,000
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $82,820 - $101,008	1,544 Added 42.64%	5,165 $338,000
Q1 2019 May 15, 2019	BUY	$49.38 - $70.58 $178,804 - $255,570	3,621 New	3,621 $214,000

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Medpace Holdings, Inc. Transaction History